Microbiota in digestive cancers: our new partner?
暂无分享,去创建一个
H. Sokol | L. Peyrin-Biroulet | F. Hansmannel | J. Bronowicki | Anthony Lopez | H. Melhem | Tunay Kokten
[1] Xin Wang,et al. Suppression of colorectal tumorigenesis by recombinant Bacteroides fragilis enterotoxin-2 in vivo , 2017, World journal of gastroenterology.
[2] M. Plummer,et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. , 2016, The Lancet. Global health.
[3] R. Landreneau,et al. Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma , 2016, BMC Cancer.
[4] N. Barnich,et al. Gut microbiota imbalance and colorectal cancer. , 2016, World journal of gastroenterology.
[5] L. Bravo,et al. Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia , 2016, Scientific Reports.
[6] F. Ginhoux,et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota , 2015, Science.
[7] Jason B. Williams,et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.
[8] D. Pardoll,et al. Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis. , 2015, Cancer discovery.
[9] Wendy S. Garrett,et al. Cancer and the microbiota , 2015, Science.
[10] P. Goldberg,et al. Quantitative Profiling of Colorectal Cancer-Associated Bacteria Reveals Associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and Clinicopathological Features of Colorectal Cancer , 2015, PloS one.
[11] S. Jonjić,et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. , 2015, Immunity.
[12] A. Mira,et al. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers , 2015, Journal of Gastroenterology.
[13] Yongfei Hu,et al. Dysbiosis of Fungal Microbiota in the Intestinal Mucosa of Patients with Colorectal Adenomas , 2015, Scientific Reports.
[14] K. Song,et al. Differences in Gastric Mucosal Microbiota Profiling in Patients with Chronic Gastritis, Intestinal Metaplasia, and Gastric Cancer Using Pyrosequencing Methods , 2014, Helicobacter.
[15] D. Klinman,et al. Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer. , 2014, Vaccine.
[16] V. Godfrey,et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. , 2014, Cancer discovery.
[17] E. Montassier,et al. Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications , 2014, Alimentary pharmacology & therapeutics.
[18] Shawn W. Polson,et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity , 2014, Nature.
[19] D. Clegg,et al. Obesity and cancer—mechanisms underlying tumour progression and recurrence , 2014, Nature Reviews Endocrinology.
[20] B. Wilson,et al. Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells , 2014, Cell.
[21] Y. Khosravi,et al. Culturable Bacterial Microbiota of the Stomach of Helicobacter pylori Positive and Negative Gastric Disease Patients , 2014, TheScientificWorldJournal.
[22] M. Bissonnette,et al. Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway , 2014, Oncogenesis.
[23] S. Kaufmann,et al. Lack of microbiota reduces innate responses and enhances adaptive immunity against Listeria monocytogenes infection , 2014, European journal of immunology.
[24] G. Trinchieri,et al. Gut microbiome and anticancer immune response: really hot Sh*t! , 2014, Cell Death and Differentiation.
[25] Z. Tian,et al. Participation of microbiota in the development of gastric cancer. , 2014, World journal of gastroenterology.
[26] M. Kleinewietfeld,et al. Gut Microbiota and the Paradox of Cancer Immunotherapy , 2014, Front. Immunol..
[27] R. Palmqvist,et al. The intratumoural subsite and relation of CD8+ and FOXP3+ T lymphocytes in colorectal cancer provide important prognostic clues , 2014, British Journal of Cancer.
[28] Cynthia L Sears,et al. Microbes, microbiota, and colon cancer. , 2014, Cell host & microbe.
[29] F. Avilés-Jiménez,et al. Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer , 2014, Scientific Reports.
[30] G. Núñez,et al. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂. , 2014, Cell host & microbe.
[31] Emmanuel Buc,et al. Colonization of the Human Gut by E. coli and Colorectal Cancer Risk , 2013, Clinical Cancer Research.
[32] Lawrence A. David,et al. Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.
[33] F. Marincola,et al. Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment , 2013, Science.
[34] Eric Vivier,et al. The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide , 2013, Science.
[35] A. Rudensky,et al. Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.
[36] Jie-shou Li,et al. Dysbiosis of Gut Fungal Microbiota is Associated With Mucosal Inflammation in Crohn’s Disease , 2013, Journal of clinical gastroenterology.
[37] Yiming Wang,et al. Association between Helicobacter pylori Infection and Pancreatic Cancer Development: A Meta-Analysis , 2013, PloS one.
[38] M. Meyerson,et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.
[39] M. R. Rubinstein,et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. , 2013, Cell host & microbe.
[40] G. Huffnagle,et al. The emerging world of the fungal microbiome. , 2013, Trends in microbiology.
[41] Masahira Hattori,et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome , 2013, Nature.
[42] S. Mazmanian,et al. Innate immune recognition of the microbiota promotes host-microbial symbiosis , 2013, Nature Immunology.
[43] M. Donnenberg,et al. An Escherichia coli Effector Protein Promotes Host Mutation via Depletion of DNA Mismatch Repair Proteins , 2013, mBio.
[44] G. Gao,et al. Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients , 2013, Microbial Ecology.
[45] G. Macfarlane,et al. Oesophageal bacterial biofilm changes in gastro‐oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality? , 2013, Alimentary pharmacology & therapeutics.
[46] J. Koch,et al. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. , 2013, Trends in immunology.
[47] Osamu Watanabe,et al. Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett’s esophagus , 2013, BMC Infectious Diseases.
[48] S. Delgado,et al. Microbiological Survey of the Human Gastric Ecosystem Using Culturing and Pyrosequencing Methods , 2013, Microbial Ecology.
[49] Philip Rosenstiel,et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. , 2013, The Journal of clinical investigation.
[50] R. Sandler,et al. Fusobacterium Is Associated with Colorectal Adenomas , 2013, PloS one.
[51] Atsuo Ochi,et al. Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. , 2012, The Journal of clinical investigation.
[52] Belgin Dogan,et al. Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota , 2012, Science.
[53] F. Clavel-Chapelon,et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study , 2012, Gut.
[54] H. Tjalsma,et al. Bacterial Responses to a Simulated Colon Tumor Microenvironment* , 2012, Molecular & Cellular Proteomics.
[55] M. Dubinsky,et al. Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis , 2012, Science.
[56] Raul Rabadan,et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. , 2012, Cancer cell.
[57] Yunwei Wang,et al. Dietary fat-induced taurocholic acid production promotes pathobiont and colitis in IL-10−/− mice , 2012, Nature.
[58] M. Karin,et al. NF‐κB and the link between inflammation and cancer , 2012, Immunological reviews.
[59] S. Lightfoot,et al. 4-hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis-infected macrophages. , 2012, Gastroenterology.
[60] Richard A. Moore,et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.
[61] B. Birren,et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. , 2012, Genome research.
[62] D. Swinkels,et al. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[63] L. Proctor,et al. The Human Microbiome Project in 2011 and beyond. , 2011, Cell host & microbe.
[64] D. Chia,et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer , 2011, Gut.
[65] V. Young,et al. Interplay between the Gastric Bacterial Microbiota and Candida albicans during Postantibiotic Recolonization and Gastritis , 2011, Infection and Immunity.
[66] Liping Zhao,et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers , 2011, The ISME Journal.
[67] J. Bertin,et al. A Functional Role for Nlrp6 in Intestinal Inflammation and Tumorigenesis , 2011, The Journal of Immunology.
[68] N. Hall,et al. Towards the Human Colorectal Cancer Microbiome , 2011, PloS one.
[69] Eoin L Brodie,et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status , 2011, The ISME Journal.
[70] L. Comstock,et al. Longitudinal Analysis of the Prevalence, Maintenance, and IgA Response to Species of the Order Bacteroidales in the Human Gut , 2011, Infection and Immunity.
[71] J. Tap,et al. Microbial Dysbiosis in Colorectal Cancer (CRC) Patients , 2011, PloS one.
[72] K. Honda,et al. Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.
[73] R. Hafidh,et al. Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8 , 2010, Molecular Cancer.
[74] M. Voulgarelis,et al. Toll-Like Receptors, Tissue Injury, and Tumourigenesis , 2010, Mediators of inflammation.
[75] F. Marincola,et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18 , 2010, The Journal of experimental medicine.
[76] S. Kwon,et al. Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB, PI3K/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathway. , 2010, International journal of oncology.
[77] P. Bork,et al. A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.
[78] D. Sargent,et al. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. , 2009, Gastroenterology.
[79] W. Hohenberger,et al. Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia , 2009, BMC gastroenterology.
[80] Zhiheng Pei,et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. , 2009, Gastroenterology.
[81] D. Harrison,et al. Attaching and Effacing Escherichia coli Downregulate DNA Mismatch Repair Protein In Vitro and Are Associated with Colorectal Adenocarcinomas in Humans , 2009, PloS one.
[82] C. Sears. Enterotoxigenic Bacteroides fragilis: a Rogue among Symbiotes , 2009, Clinical Microbiology Reviews.
[83] N. Zeps,et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[84] B. Ramakrishna,et al. Real‐time polymerase chain reaction quantification of specific butyrate‐producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer , 2008, Journal of gastroenterology and hepatology.
[85] R. Knight,et al. The Human Microbiome Project , 2007, Nature.
[86] H. Joensuu,et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study , 2007, British Journal of Cancer.
[87] Carmen Buchrieser,et al. Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells , 2006, Science.
[88] B. Gulluoglu,et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[89] U. Göbel,et al. Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice. , 2006, FEMS immunology and medical microbiology.
[90] Elisabeth M Bik,et al. Molecular analysis of the bacterial microbiota in the human stomach. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[91] Jane J. Sohn,et al. CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. , 2005, Cancer research.
[92] C. Hart,et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. , 2004, Gastroenterology.
[93] S. Martins,et al. Comparison of real-time polymerase chain reaction and hybridization assays for the detection of Escherichia coli genomic DNA in process samples and pharmaceutical-grade plasmid DNA products. , 2003, Analytical biochemistry.
[94] J. Galán,et al. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. , 2000, Science.
[95] D. Kerjaschki,et al. Association between intraepithelial Escherichia coli and colorectal cancer. , 1998, Gastroenterology.
[96] T. Dragani,et al. Libri Ricevuti: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1992 .
[97] M. Kist. [Epidemiology and diagnosis of Helicobacter pylori infection]. , 1991, Zeitschrift fur Gastroenterologie. Verhandlungsband.
[98] S. Forsythe,et al. Nitrite accumulation during anaerobic nitrate reduction by binary suspensions of bacteria isolated from the achlorhydric stomach. , 1987, Journal of general microbiology.
[99] R. Peek,et al. Pathobiology of Helicobacter pylori-Induced Gastric Cancer. , 2016, Gastroenterology.
[100] Yunwei Wang,et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il 10 2 / 2 mice , 2012 .
[101] T. Wang,et al. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. , 2011, Gastroenterology.
[102] 樫村 省吾. CD83+ dendritic cells and Foxp3+ regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer , 2008 .
[103] O. Lortholary,et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.